Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.339 | Investigations of cardiotoxicity in cancer survivors | Prof. YAN Bryan Ping Yen |
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.212 | Retrospective Database Study for Treatment Patterns of Lipid-lowering Therapy in Patients with Hypercholesterolemia or Mixed Dyslipidemia in Hong Kong, South Korea, and Taiwan (READY Study) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.242 | A single arm, multicenter, open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in participants who completed the parent Lp(a)HORIZON trial | Prof. YAN Bryan Ping Yen |
| 2024.251 | BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (Freesolve) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A randomized controlled trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.468 | AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.156 | A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.695 | Validation of a new non-invasive oscillometric device for capillary blood pressure measurement |
Dr. YAN Bryan 甄秉言 |
| 2015.538 | A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 |
Prof. YAN Bryan 甄秉言教授 |
| 2009.167 | Chinese Translation and Validation of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease | Prof. YAN Bryan |
| 2009.041 | Efficacy, Safety and Cost-Effectiveness of Drug-eluting Stents in “Real World” Hong Kong Cardiology Practice | Dr. YAN Bryan |
| 2010.595 | Hong Kong Cardiovascular Health Survey: Awareness & Knowledge of Cardiovascular Risk & Cardiovascular Risk Reduction Behaviour | Prof Yan Bryan |
| 2011.053 | Efficacy, Safety and cost-effectiveness of anti-proliferative treatment of coronary arteries with catheter-based delivery of fluid paclitaxel after bare-metal stenting to reduce restenosis in high-risk patients: A multicenter randomized controlled study | Prof Yan Bryan |
| 2013.351 | Effect of Heparin on Radial Artery Occlusion After Transradial Artery Catheterization for Coronary Angiography. | Professor YAN Bryan |
| 2010.003 | Novel care pathway for managing patients with acute urinary retention in the emergency medicine ward: a retrospective study | Ms YAM Shuk Fong Estella |
| 2013.563 | Left ventricular mass and clinical characteristics of persistent masked hypertension in Hong Kong youth - a community cohort study | Dr Yam Man Ching |
| 2024.049 | Review of efficacy and safety of MEK inhibitor for treatment of neurofibromatosis Type 1 (NF1)-associated plexiform neurofibroma (PN) in Hong Kong |
Dr Yam Kwan Ming 任君明 |
| 2016.521 | Evaluation of the association of electroencephalogram (EEG) patterns with mortality in patients with altered mental state |
Dr. YAM Kwan Ming 任君明 |
| 2011.009 | A Cross-sectional Study on Specific Upper Limb Muscle Activities and Fatigue Pattern after simulated Game with Electromyography and Synchronized Video Capture for Boccia Athletes | Ms Yam Kit Yee |
| 2012.387 | The impact of sleep deprivation on paediatric resident clinical performance in Hong Kong | Dr YAM Karen Kwan Ming |
| 2019.310 | Normal range of superior mesenteric artery on computerized tomography in young Chinese population and its correlation with retroperitoneal adipose tissue | Dr. YAM Kai Ho |
| 2019.698 | Incidence, clinical presentation, treatment modalities, and long term outcomes of Retinoblastoma in Hong Kong: Hong Kong Retinoblastoma Registry |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2023.081 | Uptake and Long-term Outcomes of Amblyopia and Strabismus Treatment among Chinese and Minority Ethnic Groups in Hong Kong | Dr. YAM Jason Cheuk Sing |
| 2023.544 | Deep Multimodal Learning Based Management of Myopia in Children | Dr. YAM Jason Cheuk Sing |
| 2023.430 | A non-inferiority, prospective, randomized, open-label, active-controlled clinical trial evaluating the efficacy and safety of rigid gas-permeable contact lenses for orthokeratology for the temporary correction of myopia 評價角膜塑形用硬性透氣接觸鏡用於暫時矯正近視的有效性和安全性的非劣效性、前瞻性、隨機、開放、陽性平行對照臨床試驗 | Dr. YAM Jason Cheuk Sing |
| 2021.534 | Low-level Red Light-Low Concentration Atropine for Myopia Progression (LAMP-3) Study |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2022.597 | Development of a biobank of 3D human retinoblastoma (RB) organoids in Hong Kong to target for in vitro evaluation of anticancer treatment for RB control |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2022.212 | Impacts of COVID-19 vaccination on the ocular surface microbiota, cornea, uvea, macular vasculature and vision in children | Prof. YAM Jason Cheuk Sing |
| 2024.129 | Repeated Low-level Red Light for Myopia Progression Study: An International, Multicenter, Multiethnic, Randomized Controlled Trial, IPOSC Study | Dr. YAM Jason Cheuk Sing |
| 2025.092 | The Impact of Ocular Microbiota Dysbiosis on Eye Disease Outcomes in Hong Kong Patients | Prof. YAM Jason Cheuk Sing |
| 2024.134 | Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study | Prof. YAM Jason Cheuk Sing |
| 2017.384 | Hong Kong Retinoblastoma Awareness Campaign |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2015.033 | Hong Kong Children Myopia Prevention Programme | Dr. YAM Jason Cheuk Sing |
| 2014.140 | Efficacy of Heparin eye drops for management of vernal keratoconjunctivitis: Randomized Controlled Trial | Dr. YAM Jason Cheuk Sing |
| 2015.656 | Augmented Surgical Dosage versus Conventional Surgical Dosage of Bilateral Lateral Rectus Recession for Intermittent Exotropia to prevent recurrence: A Randomized multi-centered Control Trial. |
Dr. YAM Jason Cheuk Sing 任卓昇 |
| 2020.342 | A study on prescribing errors in Orthopaedics Wards of Alice Ho Miu Ling Nethersole Hospital: Retrospective review and approach to enhance medication safety by pharmacists |
Miss YAM Hoi Lai 任凱麗 |
| 2009.388 | Elucidation of the role of corneal progenitor cells in development of pteryguim and its recurrence | Dr. YAM Hin Fai |
| 2025.225 | A descriptive study on safety, tolerability and myopia progression in children with myopia prescribed with 0.01% atropine eye drop | Professor Yam Cheuk Sing Jason |
| 2024.619 | Implementation of the Internet Gaming Disorder Intervention Program in Secondary School Students According to RE‑AIM and the Consolidated Framework for Implementation Research |
Prof. XUE Yang YANG Xue |
| 2022.048 | Characterizing a novel spliced isoform of the proteasome subunit ADRM1/Rpn13 in promoting liver oncogenicity through selective degradation of tumor suppressor proteins |
Dr. XU Mingjing 徐明婧 |
| 2024.693 | Effects of a health belief model based educational programme for improving medication adherence among older adults with coronary artery disease: A randomised controlled trial |
Miss Xu Mengqi 徐梦琦 |
| 2014.632 | A survey about non-traumatic injury epidemiology of children and adolescents cyclists in Hong Kong | Miss Xu Jing |
| 2008.263 | Real-time Three-Dimensional Echocardiography in Fetal Heart Scanning | Mr Xiong Yi |
| 2018.244 | A 5-year follow-up study of psychological functions of non-demented community dwelling older adults in Hong Kong. |
Dr. XIONG Shing Chuen 熊丞荃 |
| 2015.435 | Autonomic Dysfunction as Measured by Non-invasive Beat-to-beat Blood Pressure Variability Monitoring to Predict Clinical Outcome in Patients after Acute Ischemic Stroke |
Dr. XIONG Li 熊麗 |
| 2016.489 | Using Non-invasive Arterial Spin-Labeled Perfusion MRI Technique to Quantitatively Evaluate Enhanced Cerebral Perfusion Following External Counterpulsation for Ischemic Stroke Patients with Large Artery Occlusive Disease |
Dr. XIONG Li 熊麗 |
| 2015.202 | Modulation of Autonomic Dysfunction and Impaired Cerebral Autoregulation in Ischemic Stroke Following External Counterpulsation Treatment: A New Therapeutic Target in Human Stroke | Prof. XIONG Li |
| 2016.491 | The Hemodynamic Mechanisms of External Counterpulsation in the Treatment for Recent Atherosclerotic Stroke: A Randomized, Open-label, Controlled Study | Prof. XIONG Li |
| 2017.068 | The Longitudinal Evolution of Dynamic Cerebral Autoregulation and Its Role in Predicting Functional Outcome after Acute Ischemic Stroke |
Prof. XIONG Li 熊麗 |
| 2017.071 | A Multi-centre, Randomized, Controlled Clinical Trial on the Efficacy and Safety of External Counterpulsation Device in the Treatment of Ischemic Stroke |
Prof. XIONG Li 熊麗 |
Page 19 of 267.